Skip to content

Anxiety: all studies

Page 214 of 769: studies 2,131 to 2,140 of 7,689, newest first. Back to the anxiety overview

Research

10-Week Trajectories of Candidate Psychological Processes Differentially Predict Mental Health Gains from Online Dyadic versus Mindfulness Interventions: A Randomized Clinical Trial.

Journal of Clinical Medicine June 3, 2024 Malvika Godara, Tania Singer 5 citations

Background: App-based contemplative interventions, such as mindfulness-based interventions, have gained popularity for the promotion of mental health; however, the understanding of underlying intervention-specific mechanisms remains limited, especially related to novel inter-relational dyadic practices. Methods: We tested (n = 253) seven putative mechanisms underlying two brief (daily 12-min)...

The effect of 20-minute mindful breathing exercise on psychological well-being in epilepsy: A pilot randomized controlled trial.

Epilepsy & Behavior June 1, 2024 Kheng-Seang Lim, Si-Lei Fong, Xuen Yu et al. 6 citations

Depression and anxiety are prevalent in epilepsy patients, but psychiatric or psychological services may not be accessible to all patients. This study aimed to determine the effectiveness of the 20-minute mindful breathing on the psychological well-being of PWE using an instructional video. This was a pilot, assessor-blinded, randomized controlled trial. The intervention group received a guided...

Training-related improvements in mental well-being through reduction in negative interpretation bias: A randomized trial of online socio-emotional dyadic and mindfulness interventions.

Journal of Affective Disorders June 1, 2024 Malvika Godara, Martin Hecht, Tania Singer 11 citations

Effects of online contemplative practices, especially partner-based practices, on psychological well-being remain mixed, with sparse understanding of potential affective-cognitive mechanisms. The study aimed to assess the efficacy of two online contemplative interventions in improving depression, anxiety, emotion regulation (ER), and resilience, and to evaluate the mechanistic role of negative...

Not all serotonergic psychedelics are alike - they induce distinct patterns of altered metabolic activity and connectivity

May 28, 2024 Frederik Gudmundsen, Julia Czurylo, Camilla Trang Vo et al. 1 citation preprint

Serotonergic psychedelic drugs have shown promising benefits in trials for various neuropsychiatric disorders. While the acute effects of these psychedelics last only a few hours, the positive therapeutic effects can persist long after a single administration. Serotonergic psychedelics produce their psychedelic effects by activating serotonin 2A receptors, but they differ in other...

Psychedelic therapy in depression and substance use disorders

European Journal of Neuroscience May 21, 2024 Nur Damla Korkmaz, Ugur Cikrikcili, Merve Akan et al. 19 citations

Abstract Psychoactive substances obtained from botanicals have been applied for a wide variety of purposes in the rituals of different cultures for thousands of years. Classical psychedelics from N,N′‐dimethyltryptamine, psilocybin, mescaline and various lysergamides cause specific alterations in perception, emotion and cognition by acting through serotonin 5‐HT 2A receptor activation. Lysergic...

Integrating Virtual Mindfulness-Based Stress Reduction Into Inflammatory Bowel Disease Care: Mixed Methods Feasibility Trial.

JMIR Formative Research May 6, 2024 Kaitlyn Delaney Chappell, Diana Meakins, Melanie Marsh-Joyal et al. 5 citations

Individuals with inflammatory bowel disease (IBD) experience cycles of aggressive physical symptoms including abdominal pain, diarrhea, and fatigue. These acute symptoms regress and return, and chronic symptoms and complications often linger. The nature of the disease can also cause individuals to experience psychological distress including symptoms of anxiety and depression; however, unlike...

Therapeutics Uses of Psychedelics in patients with psychiatric disorders A Systematic Review

Journal For International Medical Graduates April 18, 2024 Sarosh Nawaz, Abdulaziz Mohammed Althwanay, B Esraa M. Aledani Mb Ch et al.

The impact of psychedelic treatment on patients suffering from psychiatric diseases like depression, anxiety, post-traumatic psychiatric disorder (PTSD), and existential distress related to cancer has become very intriguing to psychiatrists in the modern era. Serotonergic psychedelics include Lysergic acid diethylamide (LSD), psilocybin, mescaline, ayahuasca, and methylene-deoxy methamphetamine...

Acute Adverse Effects of Therapeutic Doses of Psilocybin

JAMA Network Open April 10, 2024 Akhila Yerubandi, Catherine Harrington, Joshua Caballero et al. 80 citations

Importance Psilocybin has been studied in the treatment of depression and anxiety disorders. Clinical studies have mainly focused on efficacy, with systematic reviews showing favorable efficacy; however, none have primarily focused on psilocybin safety. Objective To evaluate the acute adverse effects of psilocybin at therapeutic doses in the treatment of depression and anxiety. Data Sources...

EEG changes induced by meditative practices: State and trait effects in healthy subjects and in patients with epilepsy.

Revue Neurologique April 1, 2024 I Merlet, M Guillery, L Weyl et al. 9 citations

The effect of meditation on brain activity has been the topic of many studies in healthy subjects and in patients suffering from chronic diseases. These effects are either explored during meditation practice (state effects) or as a longer-term result of meditation training during the resting-state (trait). The topic of this article is to first review these findings by focusing on...